Krilogy Financial’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.81M | Sell |
7,602
-222
| -3% | -$107K | 0.11% | 153 |
|
|
2026
Q1 | $4.04M | Buy |
7,824
+6,597
| +538% | +$3.58M | 0.13% | 140 |
|
|
2025
Q4 | $769K | Buy |
1,227
+74
| +6% | +$41.8K | 0.03% | 417 |
|
|
2025
Q3 | $654K | Buy |
+1,153
| New | +$537K | 0.02% | 443 |
|
|
2023
Q2 | – | Sell |
-3,591
| Closed | -$2.07M | – | 372 |
|
|
2023
Q1 | $2.07M | Buy |
3,591
+1,552
| +76% | +$875K | 0.17% | 107 |
|
|
2022
Q4 | $1.12M | Buy |
2,039
+252
| +14% | +$134K | 0.11% | 153 |
|
|
2022
Q3 | $906K | Buy |
1,787
+27
| +2% | +$15.1K | 0.11% | 132 |
|
|
2022
Q2 | $956K | Sell |
1,760
-424
| -19% | -$233K | 0.11% | 127 |
|
|
2022
Q1 | $1.29M | Sell |
2,184
-790
| -27% | -$454K | 0.13% | 106 |
|
|
2021
Q4 | $1.98M | Sell |
2,974
-44
| -1% | -$27.5K | 0.2% | 79 |
|
|
2021
Q3 | $1.72M | Sell |
3,018
-12
| -0.4% | -$6.59K | 0.17% | 86 |
|
|
2021
Q2 | $1.53M | Buy |
3,030
+65
| +2% | +$30.7K | 0.15% | 93 |
|
|
2021
Q1 | $1.35M | Buy |
2,965
+1,217
| +70% | +$581K | 0.14% | 96 |
|
|
2020
Q4 | $814K | Buy |
1,748
+64
| +4% | +$30K | 0.1% | 137 |
|
|
2020
Q3 | $744K | Sell |
1,684
-672
| -29% | -$278K | 0.1% | 130 |
|
|
2020
Q2 | $854K | Buy |
+2,356
| New | +$790K | 0.13% | 108 |
|
|
2020
Q1 | – | Sell |
-2,338
| Closed | -$760K | – | 225 |
|
|
2019
Q4 | $760K | Buy |
2,338
+77
| +3% | +$23.3K | 0.13% | 95 |
|
|
2019
Q3 | $659K | Buy |
2,261
+478
| +27% | +$137K | 0.12% | 95 |
|
|
2019
Q2 | $524K | Buy |
1,783
+286
| +19% | +$78.8K | 0.1% | 108 |
|
|
2019
Q1 | $410K | Buy |
+1,497
| New | +$373K | 0.09% | 114 |
|
|
2018
Q4 | – | Sell |
-16
| Closed | -$4K | – | 625 |
|
|
2018
Q3 | $4K | Buy |
+16
| New | +$3.68K | ﹤0.01% | 654 |
|
|
2018
Q2 | – | Sell |
-116
| Closed | -$24K | – | 581 |
|
|
2018
Q1 | $24K | Hold |
116
| – | – | 0.01% | 425 |
|
|
2017
Q4 | $22K | Sell |
116
-265
| -70% | -$50.8K | 0.01% | 421 |
|
|
2017
Q3 | $72K | Sell |
381
-31
| -8% | -$5.61K | 0.02% | 299 |
|
|
2017
Q2 | $72K | Sell |
412
-15
| -4% | -$2.52K | 0.02% | 266 |
|
|
2017
Q1 | $60K | Hold |
427
| – | – | 0.02% | 268 |
|
|
2016
Q4 | $60K | Buy |
427
+33
| +8% | +$4.87K | 0.02% | 268 |
|
|
2016
Q3 | $63K | Buy |
394
+45
| +13% | +$6.93K | 0.02% | 273 |
|
|
2016
Q2 | $52K | Buy |
349
+2
| +0.6% | +$295 | 0.02% | 299 |
|
|
2016
Q1 | $49K | Buy |
347
+224
| +182% | +$30K | 0.02% | 266 |
|
|
2015
Q4 | $17K | Hold |
123
| – | – | 0.02% | 218 |
|
|
2015
Q3 | $15K | Buy |
+123
| New | +$16K | 0.01% | 346 |
|
Other funds holding TMO
Krilogy Financial's TMO Position: Q2 2026 in Review
Krilogy Financial reduced its Thermo Fisher Scientific (TMO) stake by 2.8% in Q2 2026, selling an estimated $107K and leaving 7,602 shares worth $3.81M. The position accounts for 0.11% of the portfolio, ranked #153.
Krilogy Financial first reported a position in TMO in Q3 2015 and has held it in 32 quarters since. The position peaked at $4.04M in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Krilogy Financial held 7,602 shares of Thermo Fisher Scientific worth $3.81M as of Q2 2026.
- Krilogy Financial sold 222 Thermo Fisher Scientific shares in Q2 2026, an estimated $107K.
- Thermo Fisher Scientific made up 0.11% of Krilogy Financial's portfolio in Q2 2026, its #153 holding.
- Krilogy Financial first reported a position in Thermo Fisher Scientific in Q3 2015 and has held it in 32 quarters since.
- Krilogy Financial's Thermo Fisher Scientific position peaked at $4.04M in Q1 2026.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.